Artelo Biosciences (ARTL) Interest Coverage Ratio (2014 - 2025)
Artelo Biosciences (ARTL) posted quarterly Interest Coverage Ratio of 107.15 for Q4 2025, up 16060.64% year-over-year from N/an in Q4 2024, and up 485.05% quarter-over-quarter from 27.83 in Q3 2025.
Artelo Biosciences (ARTL) Interest Coverage Ratio (2014 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Interest Coverage Ratio for 10 consecutive years, with 107.15 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 16060.64% year-over-year to 107.15; the TTM figure through Dec 2025 stood at 122.62 (down 6788.18% YoY), while the FY2025 annual figure was 1.46, up 18.05% from the prior year.
- Interest Coverage Ratio climbed to 107.15 in Q4 2025 per ARTL's latest filing, from 27.83 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 695.2 in Q4 2022 and bottomed at 478.8 in Q3 2022.
- Historically, Interest Coverage Ratio has averaged 58.68 across 5 years, with a median of 81.08 in 2022.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio tumbled 156.97% — and 2025, when it soared 16060.64%.
- Artelo Biosciences' Interest Coverage Ratio stood at 29.48 in 2021, then surged by 2458.49% to 695.2 in 2022, then tumbled by 111.75% to 81.69 in 2023, then soared by 99.18% to 0.67 in 2024, then jumped by 16060.64% to 107.15 in 2025.
- Business Quant data shows ARTL's Interest Coverage Ratio at 107.15 in Q4 2025, 27.83 in Q3 2025, and 5.99 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 1.42 |
| 10 | Artelo Biosciences | 112,390.15 | -487,609.85 | - | -253.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 107.15 |
| Sep 30, 2025 | -27.83 |
| Jun 30, 2025 | -5.99 |
| Mar 31, 2025 | -264.33 |
| Dec 31, 2024 | -0.67 |
| Sep 30, 2024 | -149.38 |
| Jun 30, 2024 | -125.60 |
| Mar 31, 2024 | -152.29 |
| Sep 30, 2023 | -81.69 |
| Jun 30, 2023 | -74.33 |
| Mar 31, 2023 | -208.36 |
| Dec 31, 2022 | 695.20 |
| Sep 30, 2022 | -478.80 |
| Jun 30, 2022 | -107.43 |
| Mar 31, 2022 | -81.08 |
| May 31, 2021 | -29.48 |
| Feb 28, 2021 | -12.59 |
| Nov 30, 2019 | -16.44 |
| Aug 31, 2017 | -55.02 |
| May 31, 2017 | -105.54 |